The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures

doi:10.1084/jem.183.6.2581

This Article

	Full Text (PDF, 2019K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Romas, E.
	Articles by Martin, T. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Romas, E.
	Articles by Martin, T. J.


Social Bookmarking

	What's this?

ARTICLES

The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures

E Romas, N Udagawa, H Zhou, T Tamura, M Saito, T Taga, DJ Hilton, T Suda, KW Ng and TJ Martin
St. Vincent's Institute of Medical Research, University of Melbourne, Victoria, Australia.

Interleukin (IL)-11 is a multifunctional cytokine whose role in osteoclast development has not been fully elucidated. We examined IL-11 production by primary osteoblasts and the effects of rat monoclonal anti-mouse glycoprotein 130 (gp130) antibody on osteoclast formation, using a coculture of mouse osteoblasts and bone marrow cells. IL-1, TNF alpha, PGE2, parathyroid hormone (PTH) and 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3) similarly induced production of IL-11 by osteoblasts, but IL-6, IL-4, and TGF beta did not. Primary osteoblasts constitutively expressed mRNAs for both IL-11 receptor (IL-11R alpha) and gp130. Osteotropic factors did not modulate IL-11R alpha mRNA at 24 h, but steady-state gp130 mRNA expression in osteoblasts was upregulated by 1 alpha,25(OH)2D3, PTH, or IL-1. In cocultures, the formation of multinucleated osteoclast-like cells (OCLs) in response to IL-11, or IL-6 together with its soluble IL-6 receptor was dose- dependently inhibited by rat monoclonal anti-mouse gp130 antibody. Furthermore, adding anti-gp130 antibody abolished OCL formation induced by IL-1, and partially inhibited OCL formation induced by PGE2, PTH, or 1 alpha,25(OH)2D3. During osteoclast formation in marrow cultures, a sequential relationship existed between the expression of calcitonin receptor mRNA and IL-11R alpha mRNA. Osteoblasts as well as OCLs expressed transcripts for IL-11R alpha, as indicated by RT-PCR analysis and in situ hybridization. These results suggest a central role of gp130-coupled cytokines, especially IL-11, in osteoclast development. Since osteoblasts and mature osteoclasts expressed IL-11R alpha mRNA, both bone-forming and bone-resorbing cells are potential targets of IL- 11.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Hikata, T., Takaishi, H., Takito, J., Hakozaki, A., Furukawa, M., Uchikawa, S., Kimura, T., Okada, Y., Matsumoto, M., Yoshimura, A., Nishimura, R., Reddy, S. V., Asahara, H., Toyama, Y. (2009). PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood 113: 2202-2212 [Abstract] [Full Text]
Iwasaki, K., Komaki, M., Mimori, K., Leon, E., Izumi, Y., Ishikawa, I. (2008). IL-6 Induces Osteoblastic Differentiation of Periodontal Ligament Cells. JDR 87: 937-942 [Abstract] [Full Text]
Lorenzo, J., Horowitz, M., Choi, Y. (2008). Osteoimmunology: Interactions of the Bone and Immune System. Endocr. Rev. 29: 403-440 [Abstract] [Full Text]
Nerenz, R. D., Martowicz, M. L., Pike, J. W. (2008). An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3. Mol. Endocrinol. 22: 1044-1056 [Abstract] [Full Text]
Kim, S., Yamazaki, M., Zella, L. A., Shevde, N. K., Pike, J. W. (2006). Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers.. Mol. Cell. Biol. 26: 6469-6486 [Abstract] [Full Text]
Rajgopal, R., Butcher, M., Weitz, J. I., Shaughnessy, S. G. (2006). Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway. J. Biol. Chem. 281: 20780-20787 [Abstract] [Full Text]
O'Brien, C. A., Jilka, R. L., Fu, Q., Stewart, S., Weinstein, R. S., Manolagas, S. C. (2005). IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab. 289: E784-E793 [Abstract] [Full Text]
Sohara, Y., Shimada, H., Minkin, C., Erdreich-Epstein, A., Nolta, J. A., DeClerck, Y. A. (2005). Bone Marrow Mesenchymal Stem Cells Provide an Alternate Pathway of Osteoclast Activation and Bone Destruction by Cancer Cells. Cancer Res. 65: 1129-1135 [Abstract] [Full Text]
Shin, H.-I., Divieti, P., Sims, N. A., Kobayashi, T., Miao, D., Karaplis, A. C., Baron, R., Bringhurst, R., Kronenberg, H. M. (2004). gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro. Endocrinology 145: 1376-1385 [Abstract] [Full Text]
Fu, Q., Jilka, R. L., Manolagas, S. C., O'Brien, C. A. (2002). Parathyroid Hormone Stimulates Receptor Activator of NFkappa B Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein. J. Biol. Chem. 277: 48868-48875 [Abstract] [Full Text]
Gurlek, A., Pittelkow, M. R., Kumar, R. (2002). Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation. Endocr. Rev. 23: 763-786 [Abstract] [Full Text]
Walton, K. J., Duncan, J. M., Deschamps, P., Shaughnessy, S. G. (2002). Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation. Blood 100: 2530-2536 [Abstract] [Full Text]
Li, L., Khansari, A., Shapira, L., Graves, D. T., Amar, S. (2002). Contribution of Interleukin-11 and Prostaglandin(s) in Lipopolysaccharide-Induced Bone Resorption In Vivo. Infect. Immun. 70: 3915-3922 [Abstract] [Full Text]
Vermes, C., Jacobs, J. J., Zhang, J., Firneisz, G., Roebuck, K. A., Glant, T. T. (2002). Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts. J. Biol. Chem. 277: 16879-16887 [Abstract] [Full Text]
Nakchbandi, I. A., Mitnick, M. A., Masiukiewicz, U. S., Sun, B. h., Insogna, K. L. (2001). IL-6 Negatively Regulates IL-11 Production in Vitro and in Vivo. Endocrinology 142: 3850-3856 [Abstract] [Full Text]
JONES, S. A., HORIUCHI, S., TOPLEY, N., YAMAMOTO, N., FULLER, G. M. (2001). The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15: 43-58 [Abstract] [Full Text]
Taki, H., Sugiyama, E., Kuroda, A., Mino, T., Kobayashi, M. (2000). Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cells. Rheumatology (Oxford) 39: 728-731 [Abstract] [Full Text]
Auernhammer, C. J., Melmed, S. (2000). Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function. Endocr. Rev. 21: 313-345 [Abstract] [Full Text]
Hjertner, O., Torgersen, M. L., Seidel, C., Hjorth-Hansen, H., Waage, A., Borset, M., Sundan, A. (1999). Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Secretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood 94: 3883-3888 [Abstract] [Full Text]
Grey, A., Mitnick, M.-A., Masiukiewicz, U., Sun, B.-H., Rudikoff, S., Jilka, R. L., Manolagas, S. C., Insogna, K. (1999). A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo. Endocrinology 140: 4683-4690 [Abstract] [Full Text]
O'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., Manolagas, S. C. (1999). STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-kappa B Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone. J. Biol. Chem. 274: 19301-19308 [Abstract] [Full Text]
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., Martin, T. J. (1999). Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families. Endocr. Rev. 20: 345-357 [Abstract] [Full Text]
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., Kishimoto, T. (1998). Interleukin 6�plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95: 8222-8226 [Abstract] [Full Text]
Hill, P. A., Tumber, A., Papaioannou, S., Meikle, M. C. (1998). The Cellular Actions of Interleukin-11 on Bone Resorption in Vitro. Endocrinology 139: 1564-1572 [Abstract] [Full Text]
Liu, B.-Y., Guo, J., Lanske, B., Divieti, P., Kronenberg, H. M., Bringhurst, F. R. (1998). Conditionally Immortalized Murine Bone Marrow Stromal Cells Mediate Parathyroid Hormone-Dependent Osteoclastogenesis in Vitro. Endocrinology 139: 1952-1964 [Abstract] [Full Text]
Schiller, C., Gruber, R., Redlich, K., Ho, G.-M., Katzgraber, F., Willheim, M., Pietschmann, P., Peterlik, M. (1997). 17{beta}-Estradiol Antagonizes Effects of 1{alpha},25-Dihydroxyvitamin D3 on Interleukin-6 Production and Osteoclast-Like Cell Formation in Mouse Bone Marrow Primary Cultures. Endocrinology 138: 4567-4571 [Abstract] [Full Text]
Kawasaki, K., Gao, Y.-H., Yokose, S., Kaji, Y., Nakamura, T., Suda, T., Yoshida, K., Taga, T., Kishimoto, T., Kataoka, H., Yuasa, T., Norimatsu, H., Yamaguchi, A. (1997). Osteoclasts Are Present in gp130-Deficient Mice. Endocrinology 138: 4959-4965 [Abstract] [Full Text]
Nandurkar, H. H., Robb, L., Tarlinton, D., Barnett, L., Kontgen, F., Begley, C. G. (1997). Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis. Blood 90: 2148-2159 [Abstract] [Full Text]
O'Brien, C. A., Manolagas, S. C. (1997). Isolation and Characterization of the Human gp130 Promoter. REGULATION BY STATS. J. Biol. Chem. 272: 15003-15010 [Abstract] [Full Text]
Tai, H., Miyaura, C., Pilbeam, C. C., Tamura, T., Ohsugi, Y., Koishihara, Y., Kubodera, N., Kawaguchi, H., Raisz, L. G., Suda, T. (1997). Transcriptional Induction of Cyclooxygenase-2 in Osteoblasts Is Involved in Interleukin-6-Induced Osteoclast Formation. Endocrinology 138: 2372-2379 [Abstract] [Full Text]
Du, X., Williams, D. A. (1997). Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use. Blood 89: 3897-3908 [Full Text]
Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., Gillespie, M. T. (1997). Interleukin-18 (Interferon-{gamma}-inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-{gamma} to Inhibit Osteoclast Formation. JEM 185: 1005-1012 [Abstract] [Full Text]
Zhou, H., Kartsogiannis, V., Hu, Y. S., Elliott, J., Quinn, J. M. W., McKinstry, W. J., Gillespie, M. T., Ng, K. W. (2001). A Novel Osteoblast-derived C-type Lectin That Inhibits Osteoclast Formation. J. Biol. Chem. 276: 14916-14923 [Abstract] [Full Text]